menu search

Zenas biopharma announces publication of phase 2 study of obexelimab, an investigational treatment for igg4-related disease (igg4-rd), in the lancet rheumatology

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active...

August 1, 2023, 12:23 pm

Altimmune announces initiation of phase 2b impact trial evaluating the efficacy and safety of pemvidutide in non-alcoholic steatohepatitis (nash)

GAITHERSBURG, Md., Aug. 01, 2023 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharm...

August 1, 2023, 11:30 am

Minerva neurosciences reports 2023 second quarter financial results and business updates

BURLINGTON, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage bio...

August 1, 2023, 11:30 am

Anavex life sciences to announce fiscal 2023 third quarter financial results on tuesday august 8, 2023

Webcast and Conference Call To be Held Tuesday, August 8, 2023, 8:30 am ET NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (�...

August 1, 2023, 11:30 am

Context therapeutics to participate in two august 2023 investor conferences

PHILADELPHIA, Aug. 01, 2023 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a bio...

August 1, 2023, 11:30 am

Harrow health and its interesting 11.6% 2027 baby bond

Harrow Health is an eye care pharmaceuticals company. The common stock has been on fire with expectatio...

August 1, 2023, 11:00 am

Voyageur pharmaceuticals appoints seasoned executive to board; files interim financial statements

Voyageur pharmaceuticals said it is adding experienced finance and accounting professional Kevin R. Mc...

August 1, 2023, 10:58 am

Merck's keytruda and gardasil outperform expectations, boosting annual revenue forecast

Merck & Co Inc (NYSE:MRK) saw strong sales during the second quarter for its cancer drug Keytruda and HPV vaccine Gardasil, leading the ...

August 1, 2023, 9:26 am

Pfizer slashes full-year sales forecast by $1b amidst decline in covid-related product sales

Pfizer Inc (NYSE:PFE) reduced its full-year sales forecast by $1 billion following a decline in sales for Covid-related products. The ...

August 1, 2023, 9:14 am

Why is okyo pharma (okyo) stock down 19% today?

OKYO Pharma (NASDAQ: OKYO ) stock is falling on Tuesday even after the biopharmaceutical company withd...

August 1, 2023, 9:13 am

Avicanna closes medical cannabis by shopper's acquisition; launches mymedi.ca

Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) said it has closed its previously-announced acquisition of the Medical Cannabis by Shopper's Business from Shopp...

August 1, 2023, 8:46 am

Outlook therapeutics® to present at the btig virtual biotechnology conference 2023

ISELIN, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutica...

August 1, 2023, 8:45 am

Mgc pharmaceuticals proposes fundraising for australian investors

MGC pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) said it is looking to raise up to A$2.7 million ...

August 1, 2023, 7:59 am

Clearside biomedical to report second quarter 2023 financial results and provide corporate update on monday, august 14, 2023

ALPHARETTA, Ga., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceut...

August 1, 2023, 7:05 am

Eagle pharmaceuticals to host second quarter 2023 financial results on august 8, 2023

WOODCLIFF LAKE, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Eagle pharmaceuticals, Inc. (“Eagle” or the...

August 1, 2023, 6:50 am

Merck beats on revenue boosted by keytruda sales, but posts quarterly loss due to prometheus deal

Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest ...

August 1, 2023, 6:32 am

Biogen's just made its biggest acquisition. here's what you need to know.

Biogen's revenue has been on the decline as the company relies on older products that are losing exclusivity. The acquisition of Reata ...

August 1, 2023, 5:45 am

Looking for a bargain? 3 biotech stocks to buy that are down 20%-60% in 2023

American drug makers can generate gigantic profits, pushing their stock prices to great heights. The pharmaceu...

August 1, 2023, 5:30 am

Assertio holdings, inc. closes spectrum pharmaceuticals transaction

Combination of Assertio’s Omni-Channel Digital Sales Capabilities and ROLVEDON In-Person Commercial Team to Enhance Market Access and Growth Across ...

July 31, 2023, 11:27 pm

Bolt biotherapeutics to present at btig virtual biotechnology conference 2023

REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage bio...

July 31, 2023, 9:27 pm


Search within

Pages Search Results: